SCHEMBL30289239

SCHEMBL30289239

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCCN3CCN(C(=O)OC(C)(C)C)C[C@H]3C(=O)O)cc21

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 20/20 0.51
CRBN Q96SW2 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30289039 1.00 DDB1 (0.51) DDB1CRBN
SCHEMBL30289055 0.98 DDB1 (0.50) DDB1CRBN
SCHEMBL30289119 0.98 DDB1 (0.50) DDB1CRBN
SCHEMBL30289087 0.95 DDB1 (0.52) DDB1CRBN
SCHEMBL30288925 0.95 DDB1 (0.52) DDB1CRBN
SCHEMBL23832665 0.88 DDB1 (0.55) DDB1CRBN
SCHEMBL30289147 0.87 DDB1 (0.53) DDB1CRBN
SCHEMBL30288978 0.87 DDB1 (0.53) DDB1CRBN
SCHEMBL30289322 0.86 CRBN (0.50) DDB1CRBN
SCHEMBL30288911 0.86 CRBN (0.50) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 WO disclosed